Laffer Tengler Investments Inc. Has $15.59 Million Holdings in Lam Research Corporation $LRCX

Laffer Tengler Investments Inc. boosted its holdings in Lam Research Corporation (NASDAQ:LRCX) by 18.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 116,397 shares of the semiconductor company’s stock after acquiring an additional 18,092 shares during the quarter. Lam Research accounts for about 2.5% of Laffer Tengler Investments Inc.’s investment portfolio, making the stock its 8th biggest position. Laffer Tengler Investments Inc.’s holdings in Lam Research were worth $15,586,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Howard Hughes Medical Institute bought a new stake in shares of Lam Research in the 2nd quarter valued at approximately $27,000. Sound Income Strategies LLC acquired a new stake in Lam Research in the 3rd quarter valued at $41,000. Tripletail Wealth Management LLC acquired a new position in Lam Research during the third quarter worth $44,000. Strategic Wealth Investment Group LLC acquired a new stake in shares of Lam Research in the 2nd quarter valued at $29,000. Finally, Delos Wealth Advisors LLC bought a new stake in shares of Lam Research in the 2nd quarter worth about $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Buying and Selling

In related news, CFO Douglas R. Bettinger sold 40,329 shares of Lam Research stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $230.22, for a total value of $9,284,542.38. Following the transaction, the chief financial officer directly owned 1,054,012 shares of the company’s stock, valued at $242,654,642.64. This trade represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 79,329 shares of company stock worth $18,110,542. Corporate insiders own 0.31% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Citic Securities boosted their price target on shares of Lam Research from $165.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 30th. Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. B. Riley Financial reaffirmed a “buy” rating on shares of Lam Research in a report on Thursday, January 15th. Mizuho set a $265.00 target price on Lam Research in a research note on Wednesday, January 28th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $320.00 price target (up from $265.00) on shares of Lam Research in a report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average price target of $245.19.

Lam Research Trading Down 5.9%

NASDAQ:LRCX opened at $217.27 on Wednesday. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $256.68. The business has a 50 day moving average price of $218.86 and a two-hundred day moving average price of $167.34. The company has a market cap of $271.32 billion, a P/E ratio of 44.52, a price-to-earnings-growth ratio of 2.49 and a beta of 1.77. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the prior year, the company posted $0.91 earnings per share. Lam Research’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is 21.31%.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Zacks added LRCX to its Rank #1 (Strong Buy) list, which can attract momentum and retail/quant flows into the stock. Read More.
• Positive Sentiment: Wall Street remains constructive: multiple firms have raised price targets recently (TD Cowen, Barclays, Mizuho among others) and consensus remains a “Moderate Buy,” supporting longer‑term upside expectations. Read More.
• Positive Sentiment: Lam announced a quarterly dividend (ex‑dividend March 4), a modest positive for income/total‑return investors and a signal of cash‑flow strength. Read More.
• Neutral Sentiment: Management presented at the Morgan Stanley TMT conference; the transcript provides incremental color on demand cadence and execution but did not contain fresh, market‑moving guidance. Investors will parse order trends and capex commentary for confirmation. Read More.
• Neutral Sentiment: Technical/commentary pieces flag potential near‑term upside targets, which can increase trading volatility but are speculative and not fundamental catalysts. Read More.
• Negative Sentiment: Insider selling: CFO Douglas Bettinger sold ~40,329 shares (~$9.3M) and director/officer Ava Harter sold 4,000 shares (~$930k) in early March. Large, near‑simultaneous disposals by senior insiders often trigger short‑term selling pressure and investor concern despite insiders retaining sizable stakes. Read More. Read More.
• Negative Sentiment: Near‑term market performance: reports show LRCX underperformed semiconductor peers on Monday, which can amplify algorithmic/momentum outflows and pressure the stock in the short run. Read More.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.